VISTN Vistin Pharma ASA

Vistin Pharma ASA: Annual Report 2023

Vistin Pharma ASA: Annual Report 2023

Oslo, Norway, 24 April 2024

Please find attached the Annual Report for 2023 for Vistin Pharma ASA. There are no material changes in the financial statements compared to the preliminary full year results presented on 16 February 2024.

The annual report for 2024 will also be made available on .

*****

For further information, please contact:

Alexander Karlsen

CFO



 

 

Attachments



EN
24/04/2024

Underlying

VISTNVistin Pharma ASA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Vistin Pharma ASA

 PRESS RELEASE
Free
VISTN Vistin Pharma A...

Vistin Pharma ASA: Notice of Annual General Meeting 23 May 2024

Vistin Pharma ASA: Notice of Annual General Meeting 23 May 2024 Oslo, Norway, 30 April 2024 Vistin Pharma ASA (OSE: VISTN), please find attached the call for the Annual General Meeting in Vistin Pharma, to be held on 23 May 2024 at 13:00 CEST. A physical Annual General Meeting will not be held. Instead, shareholders should authorize the Chairman of the Board. It is possible to give proxy with and without voting instructions. By using a proxy with voting instructions, the shareholders will vote on the specific issues without personal attendance. For further information on the use of ...

April 30, 2024 1 EN
 PRESS RELEASE
Free
VISTN Vistin Pharma A...

Vistin Pharma ASA: Annual Report 2023

Vistin Pharma ASA: Annual Report 2023 Oslo, Norway, 24 April 2024 Please find attached the Annual Report for 2023 for Vistin Pharma ASA. There are no material changes in the financial statements compared to the preliminary full year results presented on 16 February 2024. The annual report for 2024 will also be made available on . ***** For further information, please contact: Alexander KarlsenCFO     Attachments

April 24, 2024 1 EN
 PRESS RELEASE
Free
VISTN Vistin Pharma A...

Vistin Pharma ASA: Invitation to Q1 2024 conference call

Vistin Pharma ASA: Invitation to Q1 2024 conference call Oslo, Norway, 16 April 2024 Vistin Pharma ASA will release its first quarter results on Wednesday 24th of April 2024. Vistin Pharma will host a conference call for all shareholders and interested parties at the same day; Wednesday 24th of April at 08:30 CET. There will be a Q&A session following the management discussion. The conference call will be held in English. The first quarter conference call will be available via web and audio through the following access points: Webcast: Telephone conference (online registrati...

April 16, 2024 1 EN
 PRESS RELEASE
Free
VISTN Vistin Pharma A...

Vistin Pharma ASA: Mandatory notification of trade

Vistin Pharma ASA: Mandatory notification of trade Pactum Vekst AS has on March 22, 2024 sold 527 960 shares in Vistin Pharma ASA at a price of NOK 22,10 per share. Espen W. Marcussen, Chair of the board in Pactum Vekst AS, is a primary insider and board member of Vistin Pharma ASA. Pactum Vekst AS is fully owned by Pactum AS. The shares in Vistin Pharma are sold to one of Pactum’s shareholders, as part of a share buy-back process in Pactum. After the transaction, Pactum Vekst AS owns 2 991 773 shares in Vistin Pharma ASA. Please see attached document in accordance with the Market Abuse R...

March 22, 2024 1 EN
 PRESS RELEASE
Free
VISTN Vistin Pharma A...

Vistin Pharma ASA (VISTN) acquires minority share in CF Pharma (Hungar...

Vistin Pharma ASA (VISTN) acquires minority share in CF Pharma (Hungary) Oslo, Norway, 4 March 2024 Vistin Pharma has aquired a 15% share in CF Pharma Kft. CF Pharma is an API CDMO located in Budapest, Hungary with a broad customer base of recognized international pharmaceutical companies. CF Pharma has a proven track record in developing and commercializing Active Pharmaceutical Ingredients (APIs). The group/company currently has five commercial APIs on the market, with another eight APIs under development. The transaction price consists of a base price and an earn-out- eleme...

March 4, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch